Showing 1 - 19 results of 19 for search 'Vladimir Tesar', query time: 0.04s
Refine Results
-
1
-
2
-
3
-
4
WCN25-1898 IMPLICATIONS OF PROTEINURIA REMISSION ON ESTIMATED GLOMERULAR FILTRATION RATE (eGFR) TRAJECTORY IN PATIENTS (Pts) WITH IgA NEPHROPATHY (IgAN) IN PROTECT by Bruce Hendry, Hiddo JL Heerspink, Vladimir Tesar, Radko Komers, Priscila Preciado, Edward Murphy, Brad Rovin
Published 2025-02-01Get full text
Article -
5
WCN24-342 ATACICEPT IN IGA NEPHROPATHY: CONTINUED PROTECTIVE TITERS TO DIPHTHERIA AND TETANUS AND BALANCED INFECTIONS VS PLACEBO WITH A FOCUS ON COVID-19 by Jonathan Barratt, Bart Maes, Rubeen Israni, Xuelian Wei, Vladimir Tesar, Gerald Appel, Yusuke Suzuki, Celia Lin, Richard Lafayette
Published 2024-04-01Get full text
Article -
6
WCN24-871 HIGH-OUTPUT HEART FAILURE AMONG PATIENTS ON CHRONIC HEMODIALYSIS: NOT ONLY DUE TO HIGH FISTULA FLOW by Jan Malik, Anna Valerianova, Kristina Buryskova Salajova, Pavel Michalek, Satu Pesickova, Kristyna Michalickova, Marketa Kratochvilova, Zdenka Hruskova, Vladimir Tesar
Published 2024-04-01Get full text
Article -
7
WCN24-815 THE EFFECTS OF HEMODIALYSIS FISTULA FLOW ON THE RIGHT HEART AND ON PULMONARY HYPERTENSION by Jan Malik, Anna Valerianova, Pavel Michalek, Kristina Buryskova Salajova, Satu Pesickova, Kristyna Michalickova, Marketa Kratochvilova, Zdenka Hruskova, Vladimir Tesar
Published 2024-04-01Get full text
Article -
8
WCN24-1294 ATACICEPT REDUCES HEMATURIA AND SERUM GD-IGA1, BOTH ASSOCIATED WITH LONG-TERM RENAL OUTCOMES IN IGA NEPHROPATHY: 36-WEEK RESULTS FROM THE PHASE 2B ORIGIN STUDY by Jonathan Barratt, Bart Maes, Celia Lin, Xuelian Wei, Sean Barbour, Richard Phoon, Sung Gyun Kim, Vladimir Tesar, Jürgen Floege, Vivekanand Jha, Richard Lafayette
Published 2024-04-01Get full text
Article -
9
WCN24-1674 NEFECON TREATMENT RESPONSE IN ASIAN AND WHITE PATIENT POPULATIONS WITH IMMUNOGLOBULIN A NEPHROPATHY: A 2YEAR ANALYSIS OF THE PHASE III NEFIGARD TRIAL by Jonathan Barratt, Jens Kristensen, Andrew Stone, Jürgen Floege, Vladimír Tesař, Hernán Trimarchi, Hong Zhang, Necmi Eren, Alexander Paliege, Heather N. Reich, Brad H. Rovin, Richard Lafayette
Published 2024-04-01Get full text
Article -
10
WCN24-1774 eGFR DECLINE IN PATIENTS WITH IgAN TREATED WITH NEFECON OR PLACEBO: RESULTS FROM THE 2-YEAR NefIgArd PHASE 3 TRIAL by Richard Lafayette, Jens Kristensen, Andrew Stone, Jürgen Floege, Vladimír Tesař, Hernán Trimarchi, Hong Zhang, Necmi Eren, Alexander Paliege, Heather N. Reich, Brad H. Rovin, Jonathan Barratt
Published 2024-04-01Get full text
Article -
11
WCN24-1777 NEFECON TREATMENT PROVIDES KIDNEY BENEFITS FOR PATIENTS WITH IgAN THAT EXTEND TO THOSE WITH LOW LEVELS OF UPCR: A SUB-ANALYSIS OF THE PHASE III NefIgArd TRIAL by Jonathan Barratt, Jens Kristensen, Andrew Stone, Jürgen Floege, Vladimír Tesař, Hernán Trimarchi, Hong Zhang, Necmi Eren, Alexander Paliege, Heather N. Reich, Brad H. Rovin, Richard Lafayette
Published 2024-04-01Get full text
Article -
12
WCN24-1776 NEFECON EFFECT ON QUALITY OF LIFE IN PATIENTS WITH IgAN: SF-36 RESULTS FROM THE PHASE 3 NeFIgArd TRIAL by Jonathan Barratt, Jens Kristensen, Andrew Stone, Jürgen Floege, Vladimír Tesař, Hernán Trimarchi, Hong Zhang, Necmi Eren, Alexander Paliege, Heather N. Reich, Brad H. Rovin, Richard Lafayette
Published 2024-04-01Get full text
Article -
13
Right ventricular-pulmonary arterial coupling and pulmonary hypertension in hemodialysis: insights into structural cardiac changes and clinical implications by Kristina Buryskova Salajova, Jan Malik, Lucie Kaiserova, Zuzana Hladinova, Zdenka Hruskova, Simona Janakova, Vladimir Tesar, Satu Sinikka Pesickova, Kristyna Michalickova, Katarina Rocinova, Barbora Szonowska, Anna Valerianova
Published 2025-12-01Get full text
Article -
14
WCN24-1414 ORIGIN 3: PIVOTAL PHASE 3 STUDY EVALUATING EFFECT OF ATACICEPT VS PLACEBO ON PROTEINURIA AND RENAL FUNCTION PRESERVATION IN IGA NEPHROPATHY by Jonathan Barratt, Bart Maes, Rubeen Israni, Xuelian Wei, Jürgen Floege, Vivekanand Jha, Vladimir Tesar, Hong Zhang, Sean Barbour, Hitoshi Suzuki, Hernan Trimarchi, Celia Lin, Richard Lafayette
Published 2024-04-01Get full text
Article -
15
WCN25-2470 Long-term Results from the ORIGIN Phase 2b Study of Atacicept for the Treatment of IgAN by Vivekanand Jha, Richard Lafayette, Sean Barbour, Robert Brenner, Kerry Cooper, Xuelian Wei, Necmi Eren, Jürgen Floege, Sung Gyun Kim, Bart Maes, Richard Phoon, Harmeet Singh, Vladimír Tesař, Jonathan Barratt
Published 2025-02-01Get full text
Article -
16
Explainability of a Deep Learning-Based Classification Model for Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis by Maria A.C. Wester Trejo, Maryam Sadeghi, Shivam Singh, Naghmeh Mahmoodian, Samir Sharifli, Zdenka Hruskova, Vladimír Tesař, Xavier Puéchal, Jan Anthonie Bruijn, Georg Göbel, Ingeborg M. Bajema, Andreas Kronbichler
Published 2025-02-01Get full text
Article -
17
WCN25-499 PATIENT BASELINE CHARACTERISTICS IN THE ONGOING PHASE 3 VISIONARY TRIAL: A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF SIBEPRENLIMAB FOR IMMUNOGLOBULIN A NEPHROPATHY by Richard Lafayette, Hernan Trimarchi, Jonathan Barratt, Kevin Carroll, Vladimír Tesar, Hong Zhang, Yusuke Suzuki, Adrian Liew, Muh Geot Wong, Lokesh Shah, Jing Xia, Cecile Fajaro, Jeffrey Hafkin, Vlado Perkovic
Published 2025-02-01Get full text
Article -
18
Assessing the impact of screening, early identification and intervention programmes for chronic kidney disease: protocol for a scoping review by Vladimir Tesar, Adeera Levin, Vivekanand Jha, Ikechi G Okpechi, Roberto Pecoits-Filho, Fergus J Caskey, Magdalena Madero, Gloria Ashuntantang, Laura N Hamonic, Abduzhappar Gaipov, Elliot K Tannor, Jo-Ann Donner, Ana Figueiredo, Reiko Inagi, Charu Malik, Monica Moorthy
Published 2021-12-01Get full text
Article -
19
Clinical Presentation and Outcomes of Antineutrophil Cytoplasmic Autoantibody–Negative Pauci-Immune Glomerulonephritis by Lauren Floyd, Anamay Shetty, Adam D. Morris, Krešimir Galešić, Mohamed Elsayed, Grace Lavery, Amrita Dhutia, Sorcha O’Brien, Sinead Stoneman, Allyson Egan, Mark A. Little, Vojtech Kratky, Zdenka Hruskova, Vladimir Tesar, Marek Kollar, Anke von Bergwelt-Baildon, Ulf Schönermarck, Eveline Y. Wu, Lauren Blazek, Vimal K. Derebail, Mariam Al-Attar, Nina Brown, Beatriz Sánchez Álamo, Wing-Yin Leung, Bryan Chang, Maria Letizia Urban, Federico Alberici, Luis F. Quintana, Oliver Flossmann, Silke R. Brix, Duvuru Geetha, Stephen McAdoo, Ajay P. Dhaygude, Andreas Kronbichler, Matija Crnogorac
Published 2025-05-01Get full text
Article